INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

20,303 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
MA
Merriman Dwight ADirector
MDBMongoDB, Inc.
Open-market sale · 10b5-1 plan
SELL$166K
480 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

Page 30 of 508
← PrevNext →
6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL
$125K
500 sh
Nov 3, 2026
Nov 4, 2026
traded Nov 3, 2026
+1d
SEC Form 4

Evidence

5
DV
de Verneuil VaninaEVP, General Counsel, Corp Sec
VIRVir Biotechnology, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
1,343 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

5
BG
Baszucki GregoryDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$35K
800 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

5
WO
Winitzer OriDirector
LCIDLucid Group, Inc.
Open-market sale · 10b5-1 plan
SELL$3,090
1,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

5
BG
Baszucki GregoryDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$35K
800 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

4
BB
Borgeson BlakeDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$155K
40.0K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

3
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$25K
80 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,253
370 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$5,943
80 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
389 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
87 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
219 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

3
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
341 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

3
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
100 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
198 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

3
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
165 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
MA
Merriman Dwight ADirector
MDBMongoDB, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
83 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$39K
120 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
MA
Merriman Dwight ADirector
MDBMongoDB, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
120 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
397 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

3
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
100 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

3
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
586 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

1
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Open-market sale · 10b5-1 plan
SELL$15K
325 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

1
SR
Santana RafaelDirector, President and CEO
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Open-market sale · 10b5-1 plan
SELL$87K
302 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

1
SR
Santana RafaelDirector, President and CEO
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Open-market sale · 10b5-1 plan
SELL$151K
526 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

1
SJ
Scott JacobGENERAL COUNSEL AND CORP. SEC.
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
16.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

1
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Open-market sale · 10b5-1 plan
SELL$17K
390 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

1
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
4,901 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

1
BJ
Bertolini JeffreyChief Operating Officer
CARLCARLSMED, INC.
Open-market sale · 10b5-1 plan
SELL$11K
747 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

1
BM
Barak MariaChief Accounting Officer
RUNSunrun Inc.
Open-market sale · 10b5-1 plan
SELL$30K
3,256 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

1
DV
de Verneuil VaninaEVP, General Counsel, Corp Sec
VIRVir Biotechnology, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
2,407 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

1
SR
Santana RafaelDirector, President and CEO
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Open-market sale · 10b5-1 plan
SELL$116K
398 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

1
SR
Santana RafaelDirector, President and CEO
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Open-market sale · 10b5-1 plan
SELL$98K
334 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

0
SR
Santana RafaelDirector, President and CEO
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Open-market sale · 10b5-1 plan
SELL$38K
131 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

0
SR
Santana RafaelDirector, President and CEO
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Open-market sale · 10b5-1 plan
SELL$11K
37 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$5,398
200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
GN
Ghamsari NimaDirector, HEAD OF BLEND
BLNDBlend Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
22.3K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence